What does DVL MediQ do?

DVL MediQ is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 4 February 2020, 1 establishment.

What is the address of DVL MediQ?

The registered office of DVL MediQ is located at Sterstraat 18, 2018 Antwerpen.

Is DVL MediQ still active?

Yes. According to the CBE (5 October 2026) DVL MediQ is active, legal situation “Normale toestand”, started on 4 February 2020.

Is DVL MediQ registered on Peppol?

Yes, DVL MediQ is registered on the Peppol network with ID 0208:0742891722.

What is the enterprise number of DVL MediQ?

The enterprise number of DVL MediQ is BE0742891722.

When was DVL MediQ founded?

DVL MediQ was founded on 4 February 2020.

Who are the directors of DVL MediQ?

According to the 2025 annual accounts, the directors of DVL MediQ are: David van Laere.

Is DVL MediQ a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 February 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DVL MediQ make in 2025?

DVL MediQ recorded a loss after taxes of € 7,736 in financial year 2025.

What is the revenue of DVL MediQ?

As a small company, DVL MediQ is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 13,649.

DVL MediQ (Private Limited) - Antwerpen - BE0742891722

Dossier DVL MediQ, printed on 5 October 2026 from databakkes.be/en/0742891722/dvl-mediq. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DVL MediQ from Antwerpen, company number BE0742891722, closed financial year 2025 with a result of € -7,736 after tax. For that financial year DVL MediQ recorded a gross margin of € 13,649 and equity of € 47,902. Compared with financial year 2024, the result moved from € 25,605 to € -7,736. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 26, 2026.

What it is worth Healthy

€ 47,902

▼ 29% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -7,736

▼ still € 25,605 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 45,050

▼ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 37,902.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 7,937

▼ 33% vs 2024

€ 4,011 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 1,099

▲ 248% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,725

▼ 66% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -2,053 Gross margin 2022: € -2,053 First fiscal year in the series	€ 50,024 Gross margin 2023: € 50,024 ▲ € 52,076 vs 2022 (€ -2,053) Favourable step	€ 36,737 Gross margin 2024: € 36,737 ▼ 27% vs 2023 (€ 50,024) Unfavourable step	€ 13,649 Gross margin 2025: € 13,649 ▼ 63% vs 2024 (€ 36,737) Unfavourable step	▼ 63%
Profit after taxes	€ -2,229 Profit after taxes 2022: € -2,229 First fiscal year in the series	€ 40,449 Profit after taxes 2023: € 40,449 ▲ € 42,678 vs 2022 (€ -2,229) Favourable step	€ 25,605 Profit after taxes 2024: € 25,605 ▼ 37% vs 2023 (€ 40,449) Unfavourable step	€ -7,736 Profit after taxes 2025: € -7,736 ▼ € 33,340 vs 2024 (€ 25,605) Unfavourable step	▼ € 33,340
Equity	€ 1,583 Equity 2022: € 1,583 First fiscal year in the series	€ 42,032 Equity 2023: € 42,032 ▲ € 40,449 vs 2022 (€ 1,583) Favourable step	€ 67,637 Equity 2024: € 67,637 ▲ 61% vs 2023 (€ 42,032) Favourable step	€ 47,902 Equity 2025: € 47,902 ▼ 29% vs 2024 (€ 67,637) Unfavourable step	▼ 29%
Total debts	€ 303 Total debts 2022: € 303 First fiscal year in the series	€ 18,904 Total debts 2023: € 18,904 ▲ € 18,602 vs 2022 (€ 303) Unfavourable step	€ 26,168 Total debts 2024: € 26,168 ▲ 38% vs 2023 (€ 18,904) Unfavourable step	€ 13,761 Total debts 2025: € 13,761 ▼ 47% vs 2024 (€ 26,168) Favourable step	▼ 47%
Cash	€ 354 Cash 2022: € 354 First fiscal year in the series	€ 45,770 Cash 2023: € 45,770 ▲ € 45,416 vs 2022 (€ 354) Favourable step	€ 45,841 Cash 2024: € 45,841 Unchanged (€ 45,770) Favourable step	€ 45,050 Cash 2025: € 45,050 ▼ 2% vs 2024 (€ 45,841) Unfavourable step	▼ 2%
Retained profit	€ -8,417 Retained profit 2022: € -8,417 First fiscal year in the series	€ 32,032 Retained profit 2023: € 32,032 ▲ € 40,449 vs 2022 (€ -8,417) Favourable step	€ 57,637 Retained profit 2024: € 57,637 ▲ 80% vs 2023 (€ 32,032) Favourable step	€ 37,902 Retained profit 2025: € 37,902 ▼ 34% vs 2024 (€ 57,637) Unfavourable step	▼ 34%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 12,000 Dividend 2025: € 12,000 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 11,800 Bank debt 2024: € 11,800 Unchanged (€ 0) Unfavourable step	€ 7,937 Bank debt 2025: € 7,937 ▼ 33% vs 2024 (€ 11,800) Favourable step	▼ 33%
Balance sheet total	€ 1,886 Balance sheet total 2022: € 1,886 First fiscal year in the series	€ 60,937 Balance sheet total 2023: € 60,937 ▲ € 59,051 vs 2022 (€ 1,886) Unchanged	€ 93,805 Balance sheet total 2024: € 93,805 ▲ 54% vs 2023 (€ 60,937) Unchanged	€ 61,663 Balance sheet total 2025: € 61,663 ▼ 34% vs 2024 (€ 93,805) Unchanged	▼ 34%

Key figures of DVL MediQ, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DVL MediQ?

What happened at DVL MediQ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 26, 2026 New annual accounts for financial year 2025: loss of € 7,736 (▼ € 33,340 vs 2024). Source: NBB ↗
Feb 4, 2020 New establishment in Antwerpen. KBO
Feb 4, 2020 Start of the company according to the CBE. KBO

In short

From € 2,229 loss in 2022 to € 7,736 loss in 2025.

Paid € 17,369 in corporate taxes since 2022.

Best year ever: 2023, with € 40,449 profit.

Paid out € 12,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DVL MediQ? We notify you, reason included.

Follow DVL MediQ

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

David van Laere

DVL MediQ

Innocens

Behind DVL MediQ is David van Laere. David van Laere is also behind Innocens.

See the full network in the app

Directors

According to the 2025 annual accounts

David van Laere

Director

Also active at: Innocens

Establishments

Establishment units

Physical locations of this company

Registered office

Sterstraat 18

2018 Antwerpen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Innocens same network

€ -18,037 gross margin · 2025

Administratiekantoor Innocens

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0742.891.722

VAT number

BE 0742.891.722

Registered office

Sterstraat 18, 2018 Antwerpen

Names & denominations

DVL MediQ

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

4 February 2020

Peppol

Active · Active since 6 Jan 2026

Contact

[email protected] 0473228410

Activities · NACE

Activiteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

DVL MediQ

Financials

What happened to DVL MediQ?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions